Angela Hall

Doctor of Osteopathic Medicine,  Toronto General - University Health Network 

Location: India

Consulting Services

Admin and Customer Support Research Consulting Scientific Writing Biostatistics Pharma-CRO-Device

Areas Of Interest

Sturge-Weber Phakomatosis Synergisms, Drug Genetic Structure Informatics, Dental Therapeutic Effects Xanthomonas axonopodis Buprenorphine Naloxone Combination Angio-Conray Cerebral Aneurysmal Arteriopathy, AIDS Associated v-fms, gp120 Syndromes, Thoracic Outlet Hydantol Reno MDip Gene, araC Dianhydrosorbitol Benzethonium Collastat Postsynaptic Potential, Excitatory Surgeries, Neck Plastic Panaxs Agents, Gastrointestinal Pyrenes Energy Expenditures Norvir Autonomic Fiber, Preganglionic Angina, Unstable Medical Bibliography Sperm Motilities Worm, Segmented Deoxydemoxepam Dark Adaptation Anagen Syndromes, Loose Benadryl Pareses, Pseudobulbar Otological Diseases

Professional Narrative

Dr. Angela Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Mayo Clinic 2011
Senior Director, Mayo Clinic 2014

Education

Master of Science in physician assistant, Perelman School of Medicine 2004
Master of Science in physician assistant, Harvard Medical School 2017

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :